DOG Deutsche Ophthalmologische Gesellschaft 105. DOG-Kongress
  English Site  
  DOG Congress Home

Invitation
Organization, Deadlines
Overview of the Congress

Scientific Programme
Opening Ceremony
Ceremony 150 Years of DOG
Thursday, 20.September
Friday, 21.September
Saturday, 22.September
Sunday, 23.September
Poster Sessions
Symposia
Courses
Satellite Programme

Information
Social Programme
Sponsors, Exhibitors

DOG Homepage
 

Abstract

SO.08.03

N-acetylcysteine improves lysosomal function and enhances the degradation of photoreceptor outer segments in cultured RPE cells

Schütt F, Dithmar S, Völcker H. E.
Department of Ophthalmology, University of Heidelberg

Objective: In the retinal pigment epithelium (RPE) lipofuscin granules accumulate with age in the lysosomal compartment mainly as a byproduct of constant phagocytosis of oxidized membranous discs shed from photoreceptor outer segments. Antioxidative defiency and prooxidative conditions in the RPE play a key role in the pathogenesis of RPE dysfunction and macular degenerations such as ARMD. In human RPE cell cultures we investigated the antioxidative effect of N-acetylcysteine (ACC) on lysosomal functions.
Methods: Primary human RPE cell cultures were loaded with regular or oxidized human and porcine rod outer segments (ROS) and treated with ACC. Cell viability, lysosomal volume and metabolism of [35S]-sulfate-labeled glycosaminoglycans as exclusive lysosomal degradation pathway was measured. The regulation pattern of lysosomal proteins were investigated by proteome analysis.
Results: Using regular and oxidized ROS a small versus considerable decrease in cell viability was monitored which could be attenuated by ACC. ACC reduces total lysosomal volume in control, ROS and oxidized ROS fed RPE cells. Storage of ROS impairs glycosaminoglycan metabolism successfully damped by ACC. Furthermore, treatment with ACC leads to a general down regulation of lysosomal proteins.
Conclusions: In our cell culture model of ROS fed RPE cells simulating aged RPE ACC improves lysosomal volume and metabolism. Therefore ACC may represent a new prophylactic and causal treatment option for AMD.

 
Previous page    
Top of page